Twist Bioscience Stock Hits Day High with 9.27% Surge in Strong Performance

Twist Bioscience Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 9.27% on June 11, 2026. The stock reached an intraday high of USD 74.28, reflecting strong market activity. In terms of performance metrics, Twist Bioscience has shown impressive results over various time frames. Over the past year, the stock has delivered a remarkable 110.67% return, significantly outperforming the S&P 500, which recorded a 22.78% gain during the same period. Year-to-date, the stock has surged by 133.45%, further highlighting its robust performance. Financial indicators reveal that the company achieved its highest net sales in the last quarter, amounting to USD 110.72 million. Despite being in a loss-making position, with a net profit of USD -67.32 million, the company has demonstrated resilience, with profits rising by 49.7% over the past year. Additionally, Twist Bioscience boasts high institutional holdings at 100%, indicating strong confidence from sophisticated investors. Overall, the stock's recent activity underscores its market position and performance trends within the biotechnology landscape.